The Business Research Company’s report on the Amusement Parks Global Market Report 2025 Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
Which emerging drivers are set to accelerate the growth of the tumor ablation market further?
The growth of minimally invasive procedures is expected to propel the growth of the tumor ablation market going forward. Minimally invasive procedures are medical or surgical interventions that require only small incisions or no incisions at all. The demand for minimally invasive procedures is on the rise due to their reduced recovery times, lower risk of complications, and lower post-operative pain compared to traditional surgeries. Tumor ablation is utilized in minimally invasive procedures to destroy cancerous tissues using techniques such as radiofrequency, microwave, or cryoablation, minimizing damage to surrounding healthy tissue and reducing recovery times. For instance, in January 2024, Intuitive Surgical Inc., a US-based manufacturer of robotic products, reported that they had placed 415 da Vinci surgical systems (robotic surgical systems that use a minimally invasive surgical approach) in the fourth quarter of 2023, representing a 12% increase compared to 2022. Therefore, the growth of minimally invasive procedures is driving the growth of the tumor ablation market.
Access Your Free Sample of the Global Amusement Parks Global Market Report 2025 Market Report – Get Insights Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=17283&type=smp
What are the key factors influencing the forecasted market size of the tumor ablation industry?
The tumor ablation market size has grown rapidly in recent years. It will grow from $1.45 billion in 2024 to $1.62 billion in 2025 at a compound annual growth rate (CAGR) of 12.1%. The growth in the historic period can be attributed to the development of more precise and efficient ablation techniques, rising healthcare expenditure across emerging economies, the demographic shift towards older populations, the increasing burden of cancer, and the rising prevalence of cancer globally.
The tumor ablation market size is expected to see rapid growth in the next few years. It will grow to $2.54 billion in 2029 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to increasing cancer incidence, growing minimally invasive procedures, expanding applications, increasing healthcare cost-effectiveness, and growing awareness and education. Major trends in the forecast period include technological advancements, Continued development of advanced ablation technologies, integration of artificial intelligence, focus on outpatient settings, and patient-centric approaches.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=17283&type=smp
Who are the leading competitors in the tumor ablation market?
Major companies operating in the tumor ablation market are Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Terumo Corporation, Varian Medical Systems Inc., Merit Medical Systems Inc., Bioventus LLC, Accuray Incorporated, AtriCure Inc., AngioDynamics Inc., EDAP TMS S.A., NeuWave Medical Inc., Mirabilis Medical Inc., STARMed Co. Ltd., Profound Medical Corp., RF Medical Co. Ltd., IceCure Medical Ltd., MedWaves Inc., Chongqing Haifu Medical Technology Co. Ltd.
Which emerging trends are set to transform the tumor ablation market landscape?
Major companies operating in the tumor ablation market are developing innovative products, such as bone tumor ablation systems, to enhance treatment efficacy, improve patient outcomes, and expand the range of treatable tumors. A bone tumor ablation system is a specialized medical device used to treat bone tumors through minimally invasive procedures. For instance, in March 2024, Medtronic plc, an Ireland-based medical device company, received U.S. Food and Drug Administration (FDA) 510(k) clearance for its OsteoCool 2.bone tumor ablation system. The upgraded system is designed to treat painful bone metastases and benign bone tumors such as osteoi osteoma. The OsteoCool 2.0 allows for the simultaneous use of four internally cooled probes, enabling physicians to ablate two vertebral bodies at once or create larger ablation zones in extra-spinal applications. It delivers 20W per channel, more than twice the power of the Stryker OptaBlate bone tumor ablation system.
How do different geographies compare in terms of market share and growth potential in the tumor ablation market?
North America was the largest region in the tumor ablation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tumor ablation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Order Your Report Now For Swift Delivery
https://www.thebusinessresearchcompany.com/report/tumor-ablation-global-market-report
What are the emerging key segments in the tumor ablation market, and how are they evolving?
The tumor ablation market covered in this report is segmented –
1) By Type: Thermal Ablation, Chemical Ablation
2) By Types Of Treatment: Percutaneous, Laparoscopic, Surgical
3) By Application: Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Other Cancer
4) By End Users: Hospitals, Oncology Centers, Other End Users
Subsegments:
1) By Thermal Ablation: Radiofrequency Ablation (RFA), Microwave Ablation (MWA), Cryoablation, Laser Ablation, High-Intensity Focused Ultrasound (HIFU)
2) By Chemical Ablation: Ethanol Ablation, Acetic Acid Ablation, Chemotherapy-Based Ablation (Chemoembolization)
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17283
How is the tumor ablation market defined?
Tumor ablation is a minimally invasive medical procedure used to destroy cancerous tissues. It involves the application of extreme heat, cold, or chemical agents directly to the tumor, causing cell death. This technique is often employed for small tumors or those in difficult-to-reach locations.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
